Related Experiment Videos
Interview with Professor Jindřich Kopeček
Jindřich Kopeček1, Hannah Stanwix
1University of Utah, Department of Pharmaceutics & Pharmaceutical Chemistry, CCCD, Salt Lake City, UT 84112 USA.
Nanomedicine (London, England)
|May 16, 2014
Summary
Pioneering polymer chemistry, Jindřich Kopeček developed N-(2-hydroxypropyl)methacrylamide copolymer for cancer therapy delivery. His significant contributions advance pharmaceutical science and drug delivery systems.
Area of Science:
- Polymer Chemistry
- Pharmaceutics
- Biomedical Engineering
Background:
- Jindřich Kopeček holds a PhD in Macromolecular Chemistry and DSc in Chemistry.
- He completed postdoctoral research at the National Research Council of Canada.
- Currently a Distinguished Professor at the University of Utah, USA.
Purpose of the Study:
- To highlight the career and significant contributions of Professor Jindřich Kopeček.
- To recognize his pioneering work in polymer chemistry and drug delivery.
- To acknowledge his impact on pharmaceutical sciences and cancer therapy.
Main Methods:
- Review of academic and research achievements.
- Identification of key scientific developments.
- Analysis of publication and citation record.
Main Results:
- Dr. Kopeček's laboratory pioneered the development of N-(2-hydroxypropyl)methacrylamide copolymer.
- This copolymer serves as a crucial delivery vehicle for cancer therapy.
- He has authored over 400 publications with more than 15,000 citations.
Conclusions:
- Professor Kopeček's research has significantly advanced polymer chemistry and drug delivery.
- His work on N-(2-hydroxypropyl)methacrylamide copolymer offers a vital tool for cancer treatment.
- His extensive publication record and high citation count underscore his profound impact on pharmaceutical science.